Literature DB >> 9716981

Bioterrorism as a public health threat.

D A Henderson1.   

Abstract

The threat of bioterrorism, long ignored and denied, has heightened over the past few years. Recent events in Iraq, Japan, and Russia cast an ominous shadow. Two candidate agents are of special concern--smallpox and anthrax. The magnitude of the problems and the gravity of the scenarios associated with release of these organisms have been vividly portrayed by two epidemics of smallpox in Europe during the 1970s and by an accidental release of aerosolized anthrax from a Russian bioweapons facility in 1979. Efforts in the United States to deal with possible incidents involving bioweapons in the civilian sector have only recently begun and have made only limited progress. Only with substantial additional resources at the federal, state, and local levels can a credible and meaningful response be mounted. For longer-term solutions, the medical community must educate both the public and policy makers about bioterrorism and build a global consensus condemning its use.

Entities:  

Mesh:

Year:  1998        PMID: 9716981      PMCID: PMC2640310          DOI: 10.3201/eid0403.980340

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  4 in total

1.  National health and medical services response to incidents of chemical and biological terrorism.

Authors:  J B Tucker
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

2.  Why should we be concerned about biological warfare?

Authors:  R Danzig; P B Berkowsky
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

3.  The Sverdlovsk anthrax outbreak of 1979.

Authors:  M Meselson; J Guillemin; M Hugh-Jones; A Langmuir; I Popova; A Shelokov; O Yampolskaya
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

4.  An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe.

Authors:  P F Wehrle; J Posch; K H Richter; D A Henderson
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

  4 in total
  31 in total

Review 1.  Bioterrorism: implications for the clinical microbiologist.

Authors:  W F Klietmann; K L Ruoff
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality?

Authors:  Carlos M Morel
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

3.  Watching the Games: public health surveillance for the Sydney 2000 Olympic Games.

Authors:  L R Jorm; S V Thackway; T R Churches; M W Hills
Journal:  J Epidemiol Community Health       Date:  2003-02       Impact factor: 3.710

4.  Preparing for bioterrorism.

Authors:  P Lathrop; L M Mann
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-07

5.  Bioterrorism in 2001 - How ready are we?

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2001-03

Review 6.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

7.  Smallpox: clinical and epidemiologic features.

Authors:  D A Henderson
Journal:  Emerg Infect Dis       Date:  1999 Jul-Aug       Impact factor: 6.883

Review 8.  Global health and foreign policy.

Authors:  Harley Feldbaum; Kelley Lee; Joshua Michaud
Journal:  Epidemiol Rev       Date:  2010-04-27       Impact factor: 6.222

9.  Preparing at the local level for events involving weapons of mass destruction.

Authors:  Marna L Hoard; Janet M Williams; James C Helmkamp; Paul M Furbee; William G Manley; Floyd K Russell
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

10.  Collaboration between public health and law enforcement: new paradigms and partnerships for bioterrorism planning and response.

Authors:  Jay C Butler; Mitchell L Cohen; Cindy R Friedman; Robert M Scripp; Craig G Watz
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.